Disclosed herein is a method of applying a HORMONE REPLACEMENT THERAPY AND BIRTH CONTROL A WOMAN premenopausal, comprising ADMINSTRAR premenopausal A WOMAN THAT NEED A combined dosage form of estrogen selected from 0.5-2.0 MG 17beta-estradiol, 0.008 to 0.030 mg ethinyl estradiol and mestranol 0.015 to 0.060 MG; AND BETWEEN SELECTED PROGETOGENO 0.025 to 0.100 mg levonorgestrel, 0.010-0, 070 MG OF gestodene, 0.025 to 0.100 mg desogestrel 0.025 to 0.100 mg 3-ketodesogestrel and 0.085 to 0.35 mg norethindrone, administered such an COMBINED DOSAGE for 23-25 DAYS AND STARTING IN THE FIRST DAY OF MENSTRUAL CYCLE, FOLLOWED BY 2 TO 5 DAYS WITHOUT PILLS OR PLACEBO PILLS FOR A TOTAL OF 28 DAYS CYCLE MANAGEMENT'S. The dosage form FAVORITE invention is a combination of 1 mg 17beta-estradiol and 0.050 or 0.075 mg levonorgestrel. CYCLE MANAGEMENT OF THE INVENTION PREFERRED ADMINISTRATION OF COMBINED DOSAGE FORM DURING THE FIRST 24 DAYS OF ANY menstrual cycle and dosage form during the last 4 days of the menstrual cycle.
展开▼